$BVAXF for any former $IMVIQ holders please come and check out what's happening with $BVAXF https://ca.finance.yahoo.com/news/brittany-davison-cpa-ca-joins-120000797.html
$IMVIQ $BVAXF
https://www.prnewswire.com/news-releases/biovaxys-completes-the-acquisition-of-all-intellectual-property-immunotherapeutics-platform-technology-and-clinical-stage-assets-of-the-former-imv-inc-302067847.html
Biovaxys has no debt & low overhead. $15.43 CAP. Currently trading at 7.5 cents. $BVAXF made a sweet deal with Horizon Creditor (basically $1 million). Biovaxys is Marketing DPX Platform for licensing, but my hope is the Biovaxys/IMV platform dog & pony show for licensing attracts a big pharma buyer. All speculation. Moving up, but still super cheap right now.
$IMVIQ In case anyone still confuse about what happened to their IMV$$.
https://www.businesswire.com/news/home/20230901498366/en/IMV-Accepts-an-Offer-from-its-Secured-Lenders-for-the-Sale-of-its-Intellectual-Property-Assets
IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
September 01, 2023 04:00 PM Eastern Daylight Time
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (the “Company” or “IMV”) announces today that it has accepted an offer (the “Offer”) from IMV’s largest secured creditors (the “Secured Lenders”), pursuant to which IMV and its subsidiary, Immunovaccine Technologies Inc. have agreed to sell to the Secured Lenders its intellectual property assets (the “Transaction”) in consideration for a partial reduction of debt owing to the Secured Lenders.
$IMVIQ say hello to the future con artist ! Imvs director. What a disgrace...looked like she was already planning how to rip people off just by here Facebook posts
$IMVIQ is it true that there Is a counter claim made against The D&O for conspiracy? I am seeing posts online about a claim against the directors . Can somebody confirm this.....
$IMVIQ (appears Merck got their drug back based upon the 2010 T&Cs)
Termination for convenience by Immunovaccine
(a) Termination for convenience. Immunovaccine shall have the right to terminate this Agreement for convenience upon sixty (60) days’ advance written notice to Merck. Upon termination by Immunovaccine pursuant to this Article 10.2, all licenses and other rights granted by Merck to Immunovaccine under this Agreement, shall terminate and be of no further force or effect.
If Merck wishes to continue Product Development and requires the Product Technology and/or Immunovaccine Technology for such Product Development and Commercialization Merck shall notify Immunovaccine in writing within ninety (90) days from effective date of termination and the following shall apply:
10.3 License Grant to Merck and Payment Obligations. [Financial terms
10.4 Termination for Bankruptcy.
(a) Appointment of a trustee or
(b) Filing of application for bankruptcy,
$IMVIQ this is the number to the nova scotia security commission. +18554242499 you can make a complaint against a company and they start the investigation. I will be filling a complaint tomorrow for possible insider trading and security violations
